Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children regardless of disease severity
Description
CONCLUSION: We report that early treatment with anakinra is safe and very effective in patients with severe MIS-C. In addition, our study suggests that early treatment with anakinra is the most favorable option for patients with a higher risk to
